Skip to main content

Table 3 Haemodialysis prevalent and incident counts

From: Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study

Countries Source Year of Data HD Prevalent Count HD Incident Count Extrapolation to 2017
HD Prevalent Count HD Incident Count
Austria ERA-EDTA Registry 20141 2014 3973 814 4599.24 942.31
France ° ERA-EDTA Registry 20141 2014 41,314 8321 47,826.12 9632.60
Germany Nierenersatztherapie in Deutschland 2006–20072 2006 63,413 16,260 108,457.11 27,809.96
Italy Registro Italiano di Dialisi e Trapianto Report 2011–20133 2013 41,006 8241 49,843.22 10,017.40
Poland ERA-EDTA Registry 20141 (Section B, aggregated data)4 2014 19,345 3954 22,394.26 4577.25
Romania ^ ERA-EDTA Registry 20141 2014 14,686 2538 17,000.88 2938.05
Slovenia †† ERA-EDTA Registry 20135 2013 1349 209 1639.72 254.04
Spain ~ ERA-EDTA Registry 20141 2014 21,517 4236 24,908.62 4903.70
Switzerland ERA-EDTA Registry 20141 (Section B, aggregated data) 2014 2636 663 3051.50 767.51
United Kingdom, England only ° * ERA-EDTA Registry 20141 2014 20,556 4107 23,796.14 4754.37
  1. ° Incident counts are estimated (see ERA-EDTA Registry: Annual Report 2014 for methods[22])
  2. Incidence data for Poland not reported; incident count imputed
  3. ^ Overall prevalence of RRT is underestimated by approximately 3% due to an estimated 30% underreporting of patients living on a functioning graft
  4. †† Slovenia not included in ERA-EDTA Registry 2014, so 2013 ERA-EDTA data used[23]
  5. ~ Counts for Spain are sums of the following:
    Spain, Andalusia 4115 795
    Spain, Aragon ° 529 105
    Spain, Asturias ° 447 93
    Spain, Basque country 789 159
    Spain, Cantabria * 196 43
    Spain, Castile & León °* 1078 217
    Spain, Castile-La Mancha * 826 196
    Spain, Catalonia ° 4227 889
    Spain, Extremadura ° 590 106
    Spain, Galicia 1540 292
    Spain, Community of Madrid 2576 593
    Spain, Region of Murcia 950 158
    Spain, Navarre °* 251 61
    Spain, Valencian region 3403 529
    1. * Patients younger than 20 years of age are not reported
    2. 1 ERA-EDTA Registry: Annual Report 2014 [Ref 22]
    3. 2 Computed from 2006 dialysis prevalence (808 pmp X 95.2%HD) and incidence (213 pmp X 92.6%HD) rates from Nierenersatztherapie in Deutschland: Bericht über Dialysebehandlung und Nierentransplantation in Deutschland 2006-2007 [Ref 24] and 2006 population data (82,437,995) from Eurostat (http://ec.europa.eu/eurostat/)
    4. 3 Computed from 2013 dialysis prevalence (760 pmp X 90.4%HD) and incidence (160 pmp X 86.3%HD) rates from Registro Italiano Dialisi e Trapianto: Report 2011-2013 [Ref 25] and 2013 population data (59,685,227) from Eurostat (http://ec.europa.eu/eurostat/)
    5. 4 Prevalent count from ERA-EDTA Registry 2014¹ (Section B, aggregated data), incidence not reported; incident count imputed as Poland's HD prevalent count [19,345] X average percentage of HD incident count/HD prevalent count of 9 countries with complete data [0.2044]
    6. 5 ERA-EDTA Registry: Annual Report 2013 [Ref 23]
  6. * Patients younger than 20 years of age are not reported
  7. 1 ERA-EDTA Registry: Annual Report 2014 [22]
  8. 2 Computed from 2006 dialysis prevalence (808 pmp X 95.2%HD) and incidence (213 pmp X 92.6%HD) rates from Nierenersatztherapie in Deutschland: Bericht über Dialysebehandlung und Nierentransplantation in Deutschland 2006–2007 [24] and 2006 population data (82,437,995) from Eurostat (http://ec.europa.eu/eurostat/)
  9. 3 Computed from 2013 dialysis prevalence (760 pmp X 90.4%HD) and incidence (160 pmp X 86.3%HD) rates from Registro Italiano Dialisi e Trapianto: Report 2011–2013 [25] and 2013 population data (59,685,227) from Eurostat (http://ec.europa.eu/eurostat/)
  10. 4 Prevalent count from ERA-EDTA Registry 20141 (Section B, aggregated data), incidence not reported; incident count imputed as Poland’s HD prevalent count [19,345] X average percentage of HD incident count/HD prevalent count of 9 countries with complete data [0.2044]
  11. 5 ERA-EDTA Registry: Annual Report 2013 [23]